Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Nonketotic Hyperosmolar Coma

Diabetes and Sleep

Diabetic Neuropathy Diagnosis

Understanding MODY 5: A Rare Genetic Form of Diabetes

How Baking Soda Affects People with Type 2 Diabetes

What is Diabetic Neuropathy?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Diabetes Types

What are Nightmares and Why Do They Occur?

What is Diabetic Ketoacidosis?

Diabetic Emergencies: What to Do

See more featured articles »

What is HbA1c?

Diabetes and Pregnancy

Diabetic Coma Severe Hypoglycemia

Diabetes in Men versus Women

Diabetes in Men

Diabetic Neuropathy Symptoms

Hypoglycemic Unawareness

Risks to Infants of Diabetic Mothers

What is Diabetes?

Encapsulating Islet Cells for the Treatment of Diabetes

Cause of Diabetic Coma

Animals That Can Detect Hypoglycemia

Vitamin D and Type 2 Diabetes

Alcohol and Diabetes

Effects of Hyperglycemia on the Vascular System

What Causes Diabetic Nephropathy (Kidney Disease)?

What is a Diabetic Coma?

Diabetic Retinopathy Treatments

Diabetic Coma Treatments

How Does Semaglutide Work to Lose Weight?

History of Diabetes

Is a Plant-Based Diet Good for Type 2 Diabetes?

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Causes of Foot Pain

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Research into a Cure for Diabetes

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Red Blood Cell Morphology Changes in Diabetes

Diabetic Neuropathy Treatments

Diabetes and Mucormycosis

Supplements for Diabetes

Treatment and Prognosis for Diabetic Mastopathy

Diabetic Mastopathy Diagnosis

Diabetic Retinopathy Symptoms

Diabetic Neuropathy Pathogenesis

The Risks of Prediabetes

Genetic Testing for Diabetes

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Does the Keto Diet Increase the Risk of Diabetes?

Can I reverse my prediabetes naturally

The Impact of Glucagon on Diabetes Management

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Diabetes Management

Diabetic Hypoglycemia Treatments

Diabetes Symptoms

The Future of Diabetes Treatment

Diabetic Mastopathy: Complication of Diabetes Mellitus

How does Gestational Diabetes Affect the Baby?

Diabetes Screening

Diabetes Complications

What is Diabetic Nephropathy?

What is HbA1C Testing?

What is Diabetic Hypoglycemia?

Diabetic Retinopathy Risk Factors

Pins and Needles and Diabetes

Diabetes and Periodontitis

Low Sugar Foods for Diabetes

Advanced Diabetic Ketoacidosis

Diabetes Diagnosis

Diabetes Pathophysiology

COVID-19 and Diabetes

Diabetic Foot Problems

Diabetic Hypoglycemia Etiology

Diabetes Risk Factors

Diabetic Retinopathy Diagnosis

Walking After Meals: Small Habit, Big Metabolic Gains

Diabetic Nephropathy Treatment

Diabetes and Vision

Adiponectin and Diabetes

Diabetes and Skin Problems

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

What is Diabetic Retinopathy?

What Causes Diabetes?

Epigenetic Mechanisms in Type 2 Diabetes

Artificial Pancreas Systems: The Future of Diabetes Management?

Diabetic Nephropathy Symptoms

Diabetes and Wound Healing

Diabetic Ketoacidosis Causes

Latest Diabetes News and Research

Wegovy linked to higher risk of eye stroke and vision loss

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of 'eye stroke' (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published in the British Journal of Ophthalmology.

10 Mar 2026

Hormone asprosin linked to long-term weight changes after menopause

Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal women in the United States.

10 Mar 2026

Novel microneedle patch accelerates healing of chronic diabetic wounds using light

Researchers from Nanjing Drum Tower Hospital, Southeast University, and Wenzhou Medical University have developed a novel microneedle patch that combines MXene hydrogel with nitric oxide (NO) and hypoxia-inducible factor-1α (HIF-1α) plasmid for enhanced diabetic wound treatment.

10 Mar 2026

Study sheds new light on the link between cholesterol levels and mortality risks

A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks.

10 Mar 2026

Postbiotics may help treat PCOS by restoring microbiome balance

Emerging studies suggest postbiotics could aid PCOS management by restoring gut microbiome balance and enhancing insulin sensitivity and hormonal regulation.

10 Mar 2026

New strategy to fight chronic kidney inflammation

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also known as "zombie cells" – in diabetic kidney disease.

10 Mar 2026

EVA1A regulates fatty acid transporter CD36 in fatty liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely associated with the rapid rise in insulin resistance, obesity, and diabetes prevalence, making it one of the most common chronic liver diseases worldwide.

9 Mar 2026

Specific gut bacteria may signal long-term risk of heart and metabolic disease

Researchers analyzed gut microbiome profiles from 4,792 adults in the HELIUS cohort and tracked cardiometabolic outcomes over time to determine whether specific microbes predict disease risk. Certain microbes were linked to higher or lower cardiovascular risk, while plant-derived microbial metabolites suggested potential diet–microbiome interactions influencing heart health.

9 Mar 2026

Alcohol intake linked to lower micronutrient intake in men with type 2 diabetes

Researchers analyzed 1,565 Japanese outpatients with type 2 diabetes and found that higher alcohol consumption was associated with lower intake of several micronutrients, particularly potassium, calcium, and vitamins A and C, in younger men. The study also linked alcohol intake to a savory dietary pattern rich in rice, meat, fish, and seasonings, highlighting age- and sex-specific nutritional risks.

9 Mar 2026

Women face higher liver fibrosis risk from cardiometabolic factors than men

Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors.

9 Mar 2026

Newsom picks a dogfight with Trump and RFK Jr. on public health

California Gov. Gavin Newsom has positioned himself as a national public health leader by staking out science-backed policies in contrast with the Trump administration.

9 Mar 2026

Yale study identifies parent stress as an obesity risk factor

In recent years, rates of childhood obesity have been rising, with the U.S. Centers for Disease Control estimating in 2024 that approximately one in five children and adolescents met the clinical definition of obese.

9 Mar 2026

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was associated with lower risks of developing substance use disorders compared with SGLT-2 inhibitors. Among veterans with existing substance use disorders, GLP-1 receptor agonist use was also linked to fewer overdose events, hospitalizations, and suicide-related outcomes.

8 Mar 2026

Med14 protein drives GLP-1 benefits in pancreatic beta cells

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve cardiovascular health.

6 Mar 2026

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for the treatment of type 2 diabetes, they have since also transformed the therapeutic landscape of obesity and weight management.

6 Mar 2026

Buck Institute launches a new initiative to measure and extend human healthspan

The Buck Institute for Research on Aging today announced the launch of Healthspan Horizons, a new initiative designed to address one of the most urgent challenges in modern medicine: how to measure, understand, and extend healthspan-the years of life spent in good health.

6 Mar 2026

Weekend lie-ins may boost insulin sensitivity, but too much may backfire

This study explores the relationship between sleep patterns and insulin sensitivity, emphasizing the impact of weekday sleep and weekend catch-up on metabolism.

6 Mar 2026

Six federal scientists run out by Trump talk about the work left undone

Marc Ernstoff, a physician who has pioneered immunotherapy research and treatments for cancer patients, said his work as a federal scientist proved untenable under the Trump administration.

6 Mar 2026

BCAT2 enzyme identified as a target for diabetic foot recovery

Diabetic macrovascular complications are the main cause of death and disability in diabetes patients, of which vascular calcification is one of the key pathological mechanisms. Calcification in atherosclerotic plaque can cause stiffness and decreased compliance of the vascular wall, and induce atherosclerotic plaque rupture, which increases the risk of acute cardiovascular events.

6 Mar 2026

Drug combination shows greater weight loss while preserving muscle mass

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, such as skeletal muscle and connective tissue.

5 Mar 2026